Form 4: Centene CEO Sells Shares for Tax Obligations

Centene CEO Sarah London reported the sale of 36,061 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• Centene CEO Sarah London reported a transaction involving 36,061 shares of common stock.
• These shares were disposed of on March 15, 2026, at a price of $34.45 per share.
• The disposition was due to shares being withheld for taxes upon the vesting of previously-reported restricted stock units.
• Following this transaction, London directly owns 1,188,831 shares of common stock.
• This ownership includes 889,753 shares of previously-granted restricted stock units and performance stock units subject to vesting requirements.
• London also holds 13,449 Common Stock Options with an exercise price of $81.85, expiring on December 15, 2031.
• These performance stock options, granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if Centene's common stock closes at or above $100 per share for 20 consecutive trading days.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents the vesting of equity awards, a positive for the executive, offset by a routine tax-related share disposition which is not a discretionary sale.

Positives

• The transaction reflects the vesting of previously granted restricted stock units, indicating the executive's continued long-term incentive compensation.

Negatives

• The sale of shares, even for tax purposes, reduces the executive's direct equity stake in the company.

Future Outlook

The performance stock options held by Sarah London may become exercisable on or after December 15, 2024 (third anniversary of grant date) if Centene's common stock achieves a closing price of $100 per share for 20 consecutive trading days. A significant portion of her beneficial ownership remains subject to future vesting requirements.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one detailing tax-related share dispositions, are common for executives receiving equity compensation. While not indicative of a change in sentiment, they provide transparency into insider holdings and compensation structures within the healthcare services industry, where executive incentives are often tied to long-term stock performance.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of executive compensation, including restricted stock units and performance-based options with specific price triggers (e.g., $100 per share for 20 consecutive days), aligns with common practices in large-cap healthcare companies like UnitedHealth Group (UNH) or Anthem (now Elevance Health, ELV).
• These structures aim to align executive interests with long-term shareholder value creation. For instance, similar performance hurdles are often seen in compensation plans at companies such as CVS Health (CVS) or Humana (HUM) to incentivize sustained stock price appreciation.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and holdings, but the transaction itself is routine and not indicative of a change in company fundamentals or executive sentiment.
• Employees: No direct impact mentioned.

Next Steps

• Continued vesting of 889,753 restricted stock units and performance stock units.
• Potential exercisability of 13,449 performance stock options if Centene's common stock reaches $100 for 20 consecutive trading days on or after December 15, 2024.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares following the vesting of equity awards for Centene's CEO. It does not reflect a discretionary sale or purchase based on new information about the company's performance or outlook. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Centene, CNC, Sarah London, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Performance Stock Options, Executive Compensation, Tax Withholding